×
About 1,733 results

ALLMedicine™ Oral Lichen Planus Center

Research & Reviews  583 results

Dual-light Antibacterial Photodynamic Therapy as an Adjunctive Treatment to Triamcinolone in OLP
https://clinicaltrials.gov/ct2/show/NCT05401201

Aug 3rd, 2022 - Oral Lichen Planus (OLP) is a relatively common, chronic immune-mediated mucocutaneous disease,that usually occurs on the oral mucosa surfaces. Oral lesions are commonly multiple with a bilateral and symmetrical localization. Most affected sites i...

Infiltration of Mature KLRG1 Expressing Cytotoxic T Cells in Oral Lichen Planus.
https://doi.org/10.1007/s12105-022-01472-3
Head and Neck Pathology; Soler-Ferran D, Louis F et. al.

Jul 30th, 2022 - Oral lichen planus (OLP) is a chronic inflammatory disease affecting oral mucosa. Its pathogenesis includes T cell infiltration. T cells may be naïve or in response to antigen stimulation, progress through differentiation stages. The differentiate...

Dental Implant Treatment in Patients Suffering from Oral Lichen Planus: A Narrative Rev...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316128
International Journal of Environmental Research and Publi... Górski B

Jul 28th, 2022 - The aim of this study was to describe the complications and survival rates of dental implants placed in patients suffering from oral lichen planus (OLP) and to present recommendations for implant treatment in this group of patients through a narra...

Outcome and long-term treatment protocol for topical tacrolimus in oral lichen planus.
https://doi.org/10.1111/jdv.18457
Journal of the European Academy of Dermatology and Venere... Utz S, Suter VGA et. al.

Jul 24th, 2022 - Topical tacrolimus has been shown to be beneficial in the treatment of oral lichen planus (OLP). However, long-term effects and its optimal application protocol with gradual reduction have not been studied. Accordingly, we analysed the clinical re...

Oral lichen planus and the Thr102Cys polymorphism of HTR2A: a pilot case-control study.
https://doi.org/10.1016/S1470-2045(22)00434-X
The Lancet. Oncology; Michelon IF, do Amaral CC et. al.

Jul 16th, 2022 - Oral cancer is one of the most common types of cancer in the world, leading to over 177 000 deaths worldwide annually. The literature suggests that oral cancer might be preceded by potentially malignant oral lesions, such as oral lichen planus, a ...

see more →

Clinicaltrials.gov  76 results

Dual-light Antibacterial Photodynamic Therapy as an Adjunctive Treatment to Triamcinolone in OLP
https://clinicaltrials.gov/ct2/show/NCT05401201

Aug 3rd, 2022 - Oral Lichen Planus (OLP) is a relatively common, chronic immune-mediated mucocutaneous disease,that usually occurs on the oral mucosa surfaces. Oral lesions are commonly multiple with a bilateral and symmetrical localization. Most affected sites i...

the Oncogenic Potential of Salivary miRNA-93 and miRNA-412-3P in Oral Lichen Planus Patients
https://clinicaltrials.gov/ct2/show/NCT05400057

Jun 10th, 2022 - Oral lichen planus is one of the most common prevalent muco-cutaneous chronic diseases. The disease is definitely auto-immune type .Despite having idiopathic etiology, many risk factors can be considered including systemic diseases, psychogenic di...

Relationship Between Oral Lichen Planus and Autoimmune Thyroid Diseases
https://clinicaltrials.gov/ct2/show/NCT05403216

Jun 3rd, 2022 - On the basis of previous studies, a validation cohort will be established to explore the relationship between oral lichen planus and autoimmune thyroid diseases, and a disease efficacy prediction strategy can be formed.

Clinical and Molecular Correlates of Response to First Line Treatment in Lichen Planus
https://clinicaltrials.gov/ct2/show/NCT05330572

Apr 15th, 2022 - PARTICIPANT SELECTION AND ENROLMENT IDENTIFYING PARTICIPANTS All participants will be selected from attendants of the Oral & Maxillofacial Unit, Women's Day Clinic and Aberdeen Dental School in the Foresterhill Campus. The research team will ident...

Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.
https://clinicaltrials.gov/ct2/show/NCT04364555

Apr 13th, 2022 - The investigators want to study the effect of clobetasol in symptomatic oral lichen planus. The investigators will include 90 patients and randomly allocate them in three groups. The first group will receive active treatment both in the morning an...

see more →

News  28 results

A 31-year-old female presented with a burning rash on upper arms, groin, and axillae
https://www.mdedge.com/dermatology/article/252869/medical-dermatology/31-year-old-female-presented-burning-rash-upper-arms
Alaa Erras, Brooke Resh Sateesh, MD

Mar 17th, 2022 - Lichen planus (LP) is a chronic, pruritic, inflammatory disease that can affect the skin, hair, nails, and mucosal surfaces. The exact cause is unknown, but possible causes include medications, dental amalgam fillings, or an autoimmune reaction.

Oral Lichen Planus Treated With Plasma Rich in Growth Factors
https://www.mdedge.com/dermatology/article/252373/autoimmune-diseases/oral-lichen-planus-treated-plasma-rich-growth-factors
Eduardo Anitua, DDS, MD, PhD, Asier Eguia, DDS, PhD et. al.

Mar 3rd, 2022 - Lichen planus is a chronic inflammatory mucocutaneous disease that usually affects the skin and/or the genital and oral mucosae. 1,2 This disease classically presents with clinical relapses or outbreaks that alternate with periods of remission or l.

Oral lichen planus prevalence estimates go global
https://www.mdedge.com/dermatology/article/215311/dermatology/oral-lichen-planus-prevalence-estimates-go-global
Richard Franki

Jan 10th, 2020 - The global prevalence of oral lichen planus just received its first-ever systematic review and meta-analysis, and the resulting estimates are 0. 89% for the general population and 0.

Oral lichen planus prevalence estimates go global
https://www.mdedge.com/familymedicine/article/215311/dermatology/oral-lichen-planus-prevalence-estimates-go-global?channel=39313
MDedge Endocrinology; Richard Franki

Jan 9th, 2020 - The global prevalence of oral lichen planus just received its first-ever systematic review and meta-analysis, and the resulting estimates are 0. 89% for the general population and 0.

Antimalarial may be effective, safe for erosive oral lichen planus
https://www.mdedge.com/dermatology/article/203365/medical-dermatology/antimalarial-may-be-effective-safe-erosive-oral?channel=39313
Andrew D. Bowser

Jun 21st, 2019 - MILAN – Hydroxychloroquine sulfate may be an effective and relatively safe treatment option for moderate to severe oral lichen planus, an investigator reported at the World Congress of Dermatology. Andrew Bowser/MDedge News Dr.

see more →

Patient Education  6 results see all →